REFERENCES
- Foster, S. & Phillips, M. (1998). Economics and its contribution to the fight against malaria. Annals of Tropical Medicine and Parasitology, 92, 391–398.
- Garg, M. R., Gogtay, N. J. & Kshirsagar, N. A. (1995). Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay. Journal of the Association of Physicians of India, 44, 683–685.
- Garg, M. R., Gogtay, N. J. & Kshirsagar, N. A. (1999). Resurgence of malaria in Mumbai—is escalating chloroquine resistance a cause? Journal of the Association of Physicians of India, 47, 377–379.
- Honrado, E. R., Fungladda, W., Kamoiratanaku, P., Kitayaporn, D., Karbwang, J., Thimasarn, K. & Masngammueng, R. (1999). Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum mala in Chantiaburi, Thailand. Bulletin of the World Health Organization, 77, 235–241.
- McIntosh, H. M. & Greenwood, B. M. (1998). Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria—a systematic review. Annals of Tropical Medicine and Parasitology, 93, 265–270.
- Sturchler, D., Mittelholzer, M. L. & Kerr, L. (1993). How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Safety, 8, 160–168.
- White, N. J. (1992). Antimalarial pharmacokinetics and treatment regimens. British Journal of Clinical Pharmacology, 34, 1–10.